BD Physioject™ Disposable Autoinjector

The BD Physioject™ Disposable Autoinjector is a globally adopted, clinically validated device designed to improve the self-administration of injectable biologics for patients with chronic diseases. Since its commercial launch, over 118 million units have been sold, and it is used in eight global regions including the U.S., EU, and Japan. Its success is underpinned by strong human factors and clinical data: 90% of patients with rheumatoid arthritis found the device acceptable for self-injection, and 100% of participants in a clinical study preferred it over nurse-administered syringe injections.

Patients consistently report reduced pain, ease of use, and greater confidence due to features like the 360° drug viewing window, integrated safety needle covering system, and intuitive one-configuration design that supports various fill volumes and concentrations. The autoinjector is compatible with BD’s pre-fillable solutions and requires no customization, which simplifies integration into combination product development. Its design reduces the likelihood of dosing errors, incomplete injections, or needle exposure, with 100% effectiveness of safety features in trials.

BD supports partners with extensive regulatory documentation including human factors reports, validated directions for use, technical dossiers, and design verification data, accelerating development timelines and mitigating risk. With its proven safety, patient acceptance, and adaptability, the BD Physioject™ Disposable Autoinjector is an ideal choice for biopharma companies developing injectable therapies for conditions such as multiple sclerosis, Crohn’s disease, rheumatoid arthritis, psoriasis, and more—helping patients worldwide manage their chronic conditions more comfortably and independently.